Skip to Main Content

Paper Details

LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL.
Cancer Cell
46
2019
Author NameAffiliation
Andrew J GentlesStanford University
Francisco VegaSylvester Comprehensive Cancer Center, University of Miami
  • 1 - 2

Datasets

Release 1.2